arrow
R

Rosa Falcone

oncology and dermato-oncology department
H指数:22
被引数:1,601

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Case Report: The role of BRAF mutation in adjuvant and neoadjuvant treatment of melanoma patients: what is the optimal approach?

病例报告:BRAF突变在黑色素瘤患者辅助和新辅助治疗中的作用:最佳方案是什么?

2026-04-130
OAAI
Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients

对BP180 C末端表位的独特反应特征了免疫检查点抑制剂相关的天疱疮,并且基于BP180胞外域的ELISA能够使部分患者的快速诊断

2026-04-080
OA
Immune-Related Adverse Events in Patients with Melanoma Treated with B-RAF/MEK Target Therapy: Occurrence and Circulating Immune Cell Analysis

黑色素瘤患者接受B-RAF/MEK靶向治疗后出现的免疫相关不良事件:发生情况及循环免疫细胞分析

Cancers
IF4.4
2026-04-030
OAAI
Hematologic immune-related adverse events in skin cancer patients treated with immune checkpoint inhibitors: a case series

免疫检查点抑制剂治疗皮肤癌患者中的血液学免疫相关不良事件:一个病例系列

2026-01-060
OAAI
Anorectal melanoma: Clinico-pathological features of a rare and aggressive malignancy in a multicentric study

肛直肠黑色素瘤:一项多中心研究中的临床病理特征,一种罕见且侵袭性的恶性肿瘤

2025-03-180
PRE
Weekly carboplatin plus paclitaxel chemotherapy in advanced melanoma patients resistant to anti-PD-1 inhibitors: a retrospective, monocentric experience
2024-10-011
OAAI
Efficacy and safety of antiemetic regimens for highly emetogenic chemotherapy-induced nausea and vomiting: A systematic review and network meta-analysis

止吐方案治疗高度致吐性化疗引起的恶心和呕吐的有效性和安全性: 系统评价和网络荟萃分析

2023-04-0111
PRE